Clinigen Specialty Pharmaceuticals

On 22 September 2015, Clinigen agreed to acquire Link Healthcare to grow the Group’s presence in the AAA region (Asia, Africa and Australasia) and strengthen its global leadership position in the ethical supply of licensed and unlicensed medicines.

Specialty Pharmaceuticals
Who we are

Clinigen Specialty Pharmaceuticals acquires, revitalizes and markets niche specialty care medicines.

Why divest to clinigen

We specialize in giving medicines a new lease of life, ensuring that products will continue to be marketed and distributed responsibly once they have joined the Clinigen portfolio. 

OUR PORTFOLIO
Programs we manage

We provide access to clients’ medicines for thousands of patients all over the world through programs for medicines at every stage of the lifecycle.

Get In Touch

Contact us for expert information, advice, consultation or quotes.